Article
Emerging biomarkers in psoriatic arthritis.
IUBMB life - 1 Dec 2015
Paek So Yeon, Han Ling, Weiland Matthew, Lu Chuan-Jian, McKinnon Kathleen, Zhou Li, Lim Henry W, Elder James T, Mi Qing-Sheng
Abstract excerpt
Psoriasis is an immune-mediated skin disease which affects 2-4% of the worldwide population. Approximately 20-30% of patients with psoriasis develop psoriatic arthritis (PsA), a frequently destructive and disabling condition. As skin manifestations precede joint symptoms in nearly all patients with PsA, identification of biomarkers for early prediction of joint damage is an important clinical need. Because not...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.